Capvaxive
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Capvaxive, covering 2025-10-06 to 2025-10-06. Get the full timeline:
Most recent: EMA Authorised: Capvaxive (pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein) — Merck Sharp & Dohme B.V.